Erratum 1: Centrally administered adrenomedullin 5 activates oxytocin-secreting neurons in the hypothalamus and elevates plasma oxytocin level in rats

in Journal of Endocrinology
Keywords:

The authors and the journal apologise for errors that have occurred in this paper published in 2009 202 237–247.

The following sentence in the abstract should read as

This induction was significantly but not completely reduced by pre-treatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37) (3 nmol/rat) and the AM receptor antagonist AM-(22–52) (27 nmol/rat).

and not as published.

Further the keys to panel D of Figs 4 and 5 were also wrong. The correct figures are published in full below:

Figure 4
Figure 4

Topographical mapping of Fos-LI and OXT-LI or AVP-LI in the SON 90 min after i.c.v. administration of vehicle (A and C) or AM5 (2 nmol/rat: B and D). (A and B) Coexistence of Fos-LI and OXT-LI (▴). (C and D) Coexistence of Fos-LI and AVP-LI (▪). •, Fos-LI-positive cells; Δ, OXT-LI-positive cells; □, AVP-LI-positive cells. In each panel, two 30-μm thick coronal sections from the SON were selected. Bar indicates 50 μm.

Citation: Journal of Endocrinology 202, 3; 10.1677/JOE-09-0009e

Figure 5
Figure 5

Topographical mapping of Fos-LI and OXT-LI or AVP-LI in the PVN 90 min after i.c.v. administration of vehicle (A and C) or AM5 (2 nmol/rat: B and D). (A and B) Coexistence of Fos-LI and OXT-LI (▴). (C and D) Coexistence of Fos-LI and AVP-LI (▪). •, Fos-LI-positive cells; Δ, OXT-LI-positive cells; □, AVP-LI-positive cells. In each panel, two 30-μm thick coronal sections from the PVN were selected. Bar indicates 50 μm.

Citation: Journal of Endocrinology 202, 3; 10.1677/JOE-09-0009e

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

      Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 183 38 1
PDF Downloads 68 38 3
  • View in gallery

    Topographical mapping of Fos-LI and OXT-LI or AVP-LI in the SON 90 min after i.c.v. administration of vehicle (A and C) or AM5 (2 nmol/rat: B and D). (A and B) Coexistence of Fos-LI and OXT-LI (▴). (C and D) Coexistence of Fos-LI and AVP-LI (▪). •, Fos-LI-positive cells; Δ, OXT-LI-positive cells; □, AVP-LI-positive cells. In each panel, two 30-μm thick coronal sections from the SON were selected. Bar indicates 50 μm.

  • View in gallery

    Topographical mapping of Fos-LI and OXT-LI or AVP-LI in the PVN 90 min after i.c.v. administration of vehicle (A and C) or AM5 (2 nmol/rat: B and D). (A and B) Coexistence of Fos-LI and OXT-LI (▴). (C and D) Coexistence of Fos-LI and AVP-LI (▪). •, Fos-LI-positive cells; Δ, OXT-LI-positive cells; □, AVP-LI-positive cells. In each panel, two 30-μm thick coronal sections from the PVN were selected. Bar indicates 50 μm.